The global Cerebral Somatic Oximeters Market is estimated to be valued at US$ 195.2 Mn or Million in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cerebral somatic oximeters help monitor tissue oxygenation in real-time during surgery or childbirth through non-invasive probes placed on the forehead. They provide enhanced clinical insights by measuring regional oxygen saturation of the brain (rSO2) and tissues.
Market key trends:
One of the key trends in the cerebral somatic oximeters market is the growing adoption of wireless fetal monitoring solutions. Continuous fetal monitoring during labor and delivery is crucial. However, wired connections can restrict mother’s mobility. Wireless monitoring allows untethered movements and enables nurses to monitor multiple mothers simultaneously. This increases adoption amongst healthcare facilities. Also, the rising acceptance of sophisticated monitoring devices for high-risk pregnancies and complications such as preeclampsia is supporting the wireless fetal monitoring segment growth.
Segment Analysis
The global cerebral somatic oximeters market is segmented into device type, end-user and region. By device type, the market is classified into desktop and portable/handheld devices. Portable/handheld devices dominated the market in 2022 due to increasing adoption of portable monitoring devices across settings such as emergency care centers and operation theatres. By end-user, the market is divided into hospitals, clinics, ambulatory care centers and home care. The hospitals segment captured the largest share in 2022 owing to high usage of cerebral somatic oximeters for monitoring patients pre-surgery, post-surgery and in intensive care units.
Key Takeaways
The Global Cerebral Oximeters Market is expected to witness high growth, exhibiting CAGR of 7.9% over the forecast period, due to increasing adoption of brain function monitoring devices during surgeries. The market size for 2023 is US$ 195.2 Mn .
Regional analysis North America dominated the global market in 2022 and is expected to remain the highest revenue generating region during the forecast period. This is attributed to presence of major players, rising health awareness, and growing adoption of oximeter devices across healthcare settings.
Key players Key players operating in the cerebral somatic oximeters market are Medtronic, Nonin, Edwards Lifesciences Corporation, ISS, Inc., Masimo, Hamamatsu Photonics K.K., Mespere LifeSciences, CLINOCARE, HyperMed Imaging, Inc., Terumo Corporation, Quantek Instruments. Medtronic and Nonin captured largest market shares in 2022 owing to their established product portfolio and strong geographic presence.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.